Skip to main content

Perrigo Company Value Stock - Dividend - Research Selection

Perrigo

ISIN: IE00BGH1M568 , WKN: A1XAEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Perrigo raises quarterly dividend by 5% to 27.30 cents a share

2023-02-21
MARKET PULSE Perrigo Co. plc (PRGO) said Tuesday its board has approved a 5% hike in its quarterly dividend to 27.30 cents a share. The Dublin-based consumer self-care product maker said the new dividend is payable March 28 to shareholders of record as of March 10.

Perrigo Increases its Quarterly Dividend

2023-02-21
Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors approved a 5% increase in the Company's quarterly dividend to $0.273 per share, or $1.09 per share on an annual basis, up from $0.257 per share. This dividend increase marks the 20th consecutive year Perrigo has increased its dividend.

Perrigo raises dividend by 5% to $0.273/share

2023-02-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Perrigo raises quarterly dividend 5% to 27.3c per share

2023-02-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Perrigo Co. PLC stock rises Tuesday, outperforms market

2023-02-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Perrigo (PRGO) to Report Q4 Earnings: What's in the Cards?

2023-02-20
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

Perrigo Co. PLC stock rises Friday, outperforms market

2023-02-17
Shares of Perrigo Co. PLC rallied 2.45% to $36.41 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...

Perrigo Co. PLC stock outperforms market despite losses on the day

2023-02-16
Shares of Perrigo Co. PLC sank 0.73% to $35.54 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...

April 21st Options Now Available For Perrigo

2023-02-16
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Perrigo Co. PLC stock outperforms competitors on strong trading day

2023-02-15
Shares of Perrigo Co. PLC inched 0.45% higher to $35.80 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...